Suchergebnisse - "V92SO9WP2I"

PubPharm (1.252)

81

How the cost-effectiveness results change in the China health policy environment : an economic evaluation of glycopyrrolate/formoterol for the treatment of COPD

enthalten in: Journal of medical economics | 2022

von Wang, L. | Gu, W. | Zhang, X. | +5

82

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan : A Multicenter Cohort Study

enthalten in: International journal of chronic obstructive pulmonary disease | 2022

von Hsieh, M. | Chen, N. | Cheng, S. | +11

83

The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly

enthalten in: Contrast media & molecular imaging | 2022

von Guo, M. | Yu, C. | Li, Z.

RetractionIn: Contrast Media Mol Imaging. 2023 Jul 19;2023:9819710. - PMID 37502518

84

Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma

enthalten in: Expert review of respiratory medicine | 2022

von de Llano, L. | Naval, E. | Mejía, N. | +1

85

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease : United Kingdom Analysis Using the ETHOS Study

enthalten in: International journal of chronic obstructive pulmonary disease | 2022

von de Nigris, E. | Treharne, C. | Brighton, N. | +3

86

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

enthalten in: Therapeutic advances in respiratory disease | 2022

von Gong, Y. | Lv, Y. | Liu, H. | +2

87

A Meta-Analysis of the Differences in Serum Lipid Levels between Pregnant Women with Hypertensive Disorder Complicating Pregnancy and Nonhypertensive Disorder Complicating Pregnancy

enthalten in: BioMed research international | 2022

von Zhang, Y. | Pei, Y. | Li, N.

RetractionIn: Biomed Res Int. 2023 Oct 4;2023:9814507. - PMID 37829047

88

Glycopyrrolate for drooling in children with medical complexity under three years of age

enthalten in: Italian journal of pediatrics | 2022

von Lovardi, E. | De Ioris, M. | Lettori, D. | +9

89

Optimization and Application of an Efficient and Stable Inhalation Exposure System for Rodents

enthalten in: AAPS PharmSciTech | 2022

von Fan, Z. | Zhou, B. | Liu, Y. | +9

90

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges : A Post-Hoc Analysis of Data from ETHOS

enthalten in: International journal of chronic obstructive pulmonary disease | 2022

von Bafadhel, M. | Rabe, K. | Martinez, F. | +6